Novo Nordisk Seeks Growth Beyond Flagship Drugs with New Obesity Pill Trial
Novo Nordisk starts Phase 1 trial for oral obesity drug LX9851, a strategic move to diversify beyond GLP-1…
EU seeks minerals club to counter China supply grip
Agencies Ambassadors from the EU’s 27 member states will huddle in Brussels this week to thrash out a…
Novo Nordisk Seeks Stability with High-Profile Board Nominations
Facing a challenging period marked by significant share price volatility, Danish pharmaceutical giant Novo Nordisk is moving to…
Novo Nordisk Seeks Stability with High-Profile Board Nominations
Facing a challenging period marked by significant share price volatility, Danish pharmaceutical giant Novo Nordisk is moving to…